¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"obliterative glomerulosclerosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obliterative glomerulosclerosis
    Æó»öÅ丮±»À½Áõ, Æó»ö»ç±¸Ã¼°æÈ­Áõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obliterative endoarteritis
    Æó»öµ¿¸Æ³»¸·¿°
  • obliterative inflammation
    Æó»ö¿°Áõ
  • diabetic glomerulosclerosis
    ´ç´¢Å丮±»À½Áõ, ´ç´¢»ç±¸Ã¼°æÈ­Áõ
  • focal segmental glomerulosclerosis
    ±¹¼ÒÁ¶°¢Å丮±»À½Áõ, ±¹¼ÒºÐÀý»ç±¸Ã¼°æÈ­Áõ
  • glomerulosclerosis
    Å丮±»À½Áõ, »ç±¸Ã¼°æÈ­Áõ
  • intercapillary glomerulosclerosis
    ¸ð¼¼°ü»çÀÌÅ丮±»À½Áõ, ¸ð¼¼°ü°£»ç±¸Ã¼°æÈ­Áõ
  • intramural glomerulosclerosis
    º®¼ÓÅ丮±»À½Áõ, º®³»»ç±¸Ã¼°æÈ­Áõ
  • nodular glomerulosclerosis
    °áÀýÅ丮±»À½Áõ, °áÀý»ç±¸Ã¼°æÈ­Áõ
  • renal ablation glomerulosclerosis
    ÄáÆÏÀýÁ¦Å丮±»À½Áõ, ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulosclerosis
    Å丮±»À½Áõ, »ç±¸Ã¼°æÈ­Áõ
  • focal segmental glomerulosclerosis
    ±¹¼ÒÁ¶°¢Å丮±»À½Áõ, ±¹¼ÒºÐÀý»ç±¸Ã¼°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obliterative glomerulosclerosis
    Æó¼âÅ丮±»À½Áõ, Æó¼â»ç±¸Ã¼°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obliterative arterial disease
    Æó»öµ¿¸Æº´
  • obliterative endarteritis
    Æó¼âµ¿¸Æ³»¸·¿°
  • obliterative endoarteritis
    Æó¼âµ¿¸Æ³»¸·¿°
  • obliterative inflammation
    Æó»ö¿°Áõ
  • diabetic glomerulosclerosis
    (¢¡intercapillary glomerulosclerosis) ¸ð¼¼°üÅ丮±»À½Áõ, ¸ð¼¼°ü°£»ç±¸Ã¼°æÈ­Áõ
  • focal segmental glomerulosclerosis
    (¢¡focal glomerular sclerosis) ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • glomerulosclerosis
    Å丮±»À½Áõ, »ç±¸Ã¼°æÈ­Áõ
  • intercapillary glomerulosclerosis
    ¸ð¼¼°üÅ丮±»À½Áõ, ¸ð¼¼°ü°£»ç±¸Ã¼°æÈ­Áõ
  • intramural glomerulosclerosis
    º®¼ÓÅ丮±»À½Áõ, º®³»»ç±¸Ã¼°æÈ­Áõ
  • nodular glomerulosclerosis
    °áÀýÅ丮±»À½Áõ, °áÀý»ç±¸Ã¼°æÈ­Áõ
  • renal ablation glomerulosclerosis
    ÄáÆÏÀýÁ¦Å丮±»À½Áõ, ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulosclerosis,obliterative
    Æó¼â¼º
  • glomerulosclerosis
    »ç±¸Ã¼°æÈ­Áõ.
  • glomerulosclerosis
    »ç±¸Ã¼°æÈ­Áõ.(¡­Ìãûùñø)
  • glomerulosclerosis
    »ç±¸Ã¼°æÈ­(Áõ)
  • glomerulosclerosis,capsular drop
    ÇǸ·¼ÒÀû ÇǸ·¼Ò¹æ¿ï
  • glomerulosclerosis,diabetic
    ´ç´¢º´¼º
  • glomerulosclerosis,fibrin cap
    ¼¶À¯¼Òµ¤°³
  • glomerulosclerosis,focal segmental
    ÃÊÁ¡¼º ºÐÀý¼º
  • glomerulosclerosis,intercapillary
    ¸ð¼¼Ç÷°ü»çÀÌ
  • glomerulosclerosis,nodular
    °áÀý¼º
  • renal ablation glomerulosclerosis
    ½ÅÀýÁ¦»ç±¸Ã¼°æÈ­Áõ(ãìï·ð¶ÞêϹô÷Ìãûùñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulosclerosis,obliterative
    Æó¼â¼º
  • endarteritis, obliterative
    µ¿¸Æ³»¸·¿°, Æó¼â¼º
  • obliterative
    Æó»ö(¼º)(øÍßáàõ)ÀÇ.
  • obliterative arterial disease
    Æó»ö¼º µ¿¸ÆÁúȯ(øÍßáàõÔÑØæòðü´).
  • obliterative bronchitis
    Æó»ö¼º ±â°üÁö¿°(øÍßáàõѨηò«æú).
  • obliterative endoarteritis
    Æó»ö¼º(Æó¼â¼º) µ¿¸Æ³»¸·¿°(¡­(øÍáðàõ) ÔÑØæÒ®Ø¯æú)
  • obliterative inflammation
    Æó»ö¼º ¿°Áõ.
  • obliterative inflammation
    Æó»ö¼º ¿°Áõ(¡­æúñø)
  • diabetic glomerulosclerosis
    ´ç´¢º´(¼º) »ç±¸Ã¼°æÈ­Áõ(¡­ÞêϹô÷Ìãûùñø).
  • diabetic glomerulosclerosis
    ´ç´¢º´¼º »ç±¸Ã¼°æÈ­Áõ(¡­ÞêϹô÷Ìãûùñø)
  • focal glomerulosclerosis
    ÃÊÁ¡¼º »ç±¸Ã¼°æÈ­Áõ.
  • focal glomerulosclerosis
    ±¹¼Ò »ç±¸Ã¼°æÈ­
  • focal segmental glomerulosclerosis; FSGS
    ±¹¼Ò¼ººÐÀý¼º»ç±¸Ã¼°æÈ­(Áõ)
  • glomerulosclerosis
    »ç±¸Ã¼°æÈ­(Áõ)
  • glomerulosclerosis
    »ç±¸Ã¼°æÈ­Áõ.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulosclerosis
    »ç±¸Ã¼°æÈ­Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OB obese [mouse]; obese, obesity; objective benefit; obliterative bronchiolitis; obstetrics, obstetrici...
OPH obliterative pulmonary hypertension; ophthalmia
DGS decompression sickness; developmental Gerstmann syndrome; diabetic glomerulosclerosis; Di George seq...
FGG fibrinogen gamma; focal global glomerulosclerosis; fowl gamma-globulin
FSGS focal segmental glomerulosclerosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OB Obliterative bronchiolitis
FSGS Focal Segmental Glomerulosclerosis
FSGS Focal and segmental glomerulosclerosis
FGS Focal glomerulosclerosis
FGS Focal segmental glomerulosclerosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diabetic glomerulosclerosis
    ´ç´¢º´¼º »ç±¸Ã¼ °æÈ­Áõ
    ½Å ÁúȯÀÇ ÀÌȯÀ² ¹× »ç¸Á·üÀÇ ÁÖ¿ä¿øÀÎ. ¸»±â ½Å ÁúȯÀº ¿¬¼Ò¼º ´ç´¢º´ ȯÀÚÀÇ 30%¿¡¼­ °üÂûµÇ¸ç, 40¼¼ ÀÌÇÏÀÇ È¯ÀÚ »ç¸ÁÀÇ 20%¸¦ Â÷ÁöÇÑ´Ù. ´ç´¢º´¼º ½Å ÁúȯÀº ´ç´¢º´ ȯÀÚ¿¡ º´¹ßµÇ´Â ¸ðµç ½ÅÀå º´º¯À» ÃÑĪÇϸç, »ç±¸Ã¼ ħ¹üÀÌ °¡Àå ÈçÇÑ º´º¯ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î ºñ ½Å ÁõÈıº¼º ´Ü¹é´¢, ½Å ÁõÈıº, ¸¸¼º ½ÅºÎÀüÀÇ »ç±¸Ã¼¼º ÀÓ»ó±ºÀ¸·Î ¹ßÇöµÈ´Ù. ±×·¯³ª ´ç´¢º´Àº ¼¼µ¿¸ÆÀ» ħ¹üÇÏ¿© ¼¼µ¿¸Æ °æÈ­ÁõÀ» À¯¹ßÇÏ°í ½Å¿ì½Å¿°¿¡ ÀÌȯµÇ±â ½¬¿ì¸ç ½Å ¼öÁúÀÇ À¯µÎ ±«»ç ¹× °¢Á¾ ¼¼´¢°ü¼º º´º¯À» ÃÊ·¡ÇÑ´Ù.
  • obliterative arterial disease
    Æó»ö¼º µ¿¸Æ Áúȯ
  • obliterative inflammation
    Æó»ö¼º ¿°Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
obliterative arachnoiditis Thickening of the leptomeninges, sometimes with obliteration of the subarachnoid space; commonly related to acute or chronic leptomeningitis of bacterial or chemical origin.
See: leptomeningeal fibrosis.
Synonym: obliterative arachnoiditis.
(05 Mar 2000)
glomerulosclerosis Hyaline deposits or scarring within the renal glomeruli, a degenerative process occurring in association with renal arteriosclerosis or diabetes.
Synonym: glomerular sclerosis.
Origin: Glomerulus + G. Sklerosis, hardness
(05 Mar 2000)
glomerulosclerosis, focal Glomerular disease characterised by focal and segmental areas of glomerular sclerosis, usually commencing in the juxtamedullary glomeruli and gradually spreading to involve other parts of the kidney, with eventual kidney failure.
(12 Dec 1998)
segmental glomerulosclerosis <nephrology> A kidney disorder that results in fibrosis and scarring in the kidney glomerulus. The cause is unknown but some cases can result from reflux nephropathy. The clinical manifestation of this kidney disorder is nephrotic syndrome.
Symptoms include weight gain, swelling, hypertension and foamy urine. High blood cholesterol and triglyceride levels are also seen with this disorder. Treatment has included the use of corticosteroids and immunosuppressives. Antihypertensive agents and diuretics may also be necessary. Over one-half will develop chronic renal failure within 10 years of diagnosis.
(27 Sep 1997)
diabetic glomerulosclerosis Kidney disease and resultant kidney function impairment due to the long standing effects of diabetes on the microvasculature (glomerulus) of the kidney. Features include increased urine protein and declining kidney function. Severe diabetic nephropathy can lead to kidney failure and end-stage renal disease.
(27 Sep 1997)
intercapillary glomerulosclerosis Kidney disease and resultant kidney function impairment due to the long standing effects of diabetes on the microvasculature (glomerulus) of the kidney. Features include increased urine protein and declining kidney function. Severe diabetic nephropathy can lead to kidney failure and end-stage renal disease.
(27 Sep 1997)
focal segmental glomerulosclerosis <nephrology> A kidney disorder that results in fibrosis and scarring in the kidney glomerulus. The cause is unknown but some cases can result from reflux nephropathy. The clinical manifestation of this kidney disorder is nephrotic syndrome.
Symptoms include weight gain, swelling, hypertension and foamy urine. High blood cholesterol and triglyceride levels are also seen with this disorder. Treatment has included the use of corticosteroids and immunosuppressives. Antihypertensive agents and diuretics may also be necessary. Over one-half will develop chronic renal failure within 10 years of diagnosis.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • obliterative
    ¸»¼ÒÇÏ´Â;Áö¿ï ÈûÀÌ ¾ø´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á